Trial Profile
A study comparing adherence with rivaroxaban and apixaban treatment among patients with nonvalvular atrial fibrillation in routine clinical practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2017
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban (Primary)
- Indications Stroke; Thrombosis
- Focus Therapeutic Use
- 03 Apr 2017 New trial record